Citicoline Sodium Injection

This product is a nucleoside derivative, which promotes brain metabolism and improves brain circulation by reducing cerebrovascular resistance and increasing cerebral blood flow. In addition, it can enhance the function of the ascending activation system of the brainstem reticular structure, enhance the function of the pyramidal system, and improve motor paralysis, so it has a certain effect on promoting the recovery of brain function and promoting awakening.

Its chemical name is: monosodium salt of choline cytosine diphosphate.

This product is a colorless clear liquid.

Coenzyme. Used for acute craniocerebral trauma and postoperative consciousness disorder.

Intravenous drip: 0.25-0.5 g per day, diluted with 5% or 10% glucose injection and slowly dripped, every 5-10 days as a course of treatment; simple intravenous injection: 100-200 mg each time. Intramuscular injection: 0.1-0.3 g per day, divided into 1-2 injections.

This product has no obvious toxic effects on humans and animals, and has no effect on respiration, pulse, and blood pressure. Occasionally, there may be a transient drop in blood pressure, insomnia, excitement, and fever after administration, which will disappear after stopping the drug.

Not yet clear.

Precautions for children: This test has not been conducted and there is no reliable reference. Precautions for pregnancy and lactation: Not yet clear Precautions for the elderly: Not yet clear

Not yet clear.

Sealed and light-proof.

2 ml: 0.25 g

36 months

Changzhou Pharmaceutical Factory Co., Ltd.

• Founded in:

  2001-12-14

• Address:

  No. 518, Laodong East Road, Changzhou

• Tax NO.:

  91320400137158490L

• Registered Funds:

  108 million yuan

• Website:

  Log in to view

• Email:

  Log in to view